Holen Sie sich die Stockscreener-App
110.95
0.84%
0.92
Vorhandelsmarkt:
112.50
1.55
+1.40%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$110.03
Offen:
$108.55
24-Stunden-Volumen:
9.76M
Relative Volume:
0.89
Marktkapitalisierung:
$274.03B
Einnahmen:
$64.93B
Nettoeinkommen (Verlust:
$18.26B
KGV:
15.25
EPS:
7.2751
Netto-Cashflow:
$12.36B
1W Leistung:
-1.72%
1M Leistung:
-7.26%
6M Leistung:
+28.15%
1J Leistung:
+30.98%
1-Tages-Spanne:
$107.90
$111.22
1-Wochen-Bereich:
$107.90
$115.02
52-Wochen-Spanne:
$73.31
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
110.95 | 271.76B | 64.93B | 18.26B | 12.36B | 7.2751 |
LLY
Lilly Eli Co
|
851.21 | 780.79B | 65.18B | 20.64B | 5.96B | 22.59 |
JNJ
Johnson Johnson
|
227.35 | 548.34B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
203.89 | 349.67B | 62.82B | 3.62B | 17.82B | 2.0331 |
AZN
Astrazeneca Plc
|
185.20 | 289.51B | 58.80B | 10.24B | 8.98B | 3.2788 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck posts quarterly loss due to Cidara charge, sales rise 5% - Reuters
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones - Yahoo Finance UK
Merck & Co. Inc. Stock (US58933Y1055): HSR Waiting Period Expires for Terns Pharmaceuticals Acquisit - AD HOC NEWS
Vest Financial LLC Has $7.63 Million Position in Merck & Co., Inc. $MRK - MarketBeat
GC Wealth Management RIA LLC Sells 22,336 Shares of Merck & Co., Inc. $MRK - MarketBeat
Narwhal Capital Management Reduces Stake in Merck & Co., Inc. $MRK - MarketBeat
Sun Pharma to acquire Merck spinoff Organon for $11.75B - BioWorld News
Bulk Filtration Market Report 2026, Competitive Analysis of 3M, Eaton, Parker-Hannifin, Pentair, Merck, Danaher, Mann+Hummel - GlobeNewswire Inc.
Wealthfront Advisers LLC Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
FengHe Fund Management Pte. Ltd. Invests $44.25 Million in Merck & Co., Inc. $MRK - MarketBeat
Mitsubishi UFJ Trust & Banking Corp Sells 825,324 Shares of Merck & Co., Inc. $MRK - MarketBeat
Pictet Asset Management Holding SA Decreases Position in Merck & Co., Inc. $MRK - MarketBeat
Nine baseball teams join Merck to warn fans about bad cholesterol - Stock Titan
Antibiotic Resistance Market to Grow at 5.4% CAGR Reaching USD 12.72 Billion by 2031, Driven by Rising Drug-Resistant Infections and Antimicrobial Innovation: Mordor Intelligence - GlobeNewswire Inc.
Merck & Co., Inc. $MRK Shares Bought by AMG National Trust Bank - MarketBeat
Merck: Bullish Setup Into Q1 Earnings - Seeking Alpha
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
State of Michigan Retirement System Sells 13,300 Shares of Merck & Co., Inc. $MRK - MarketBeat
Comerica Bank Reduces Position in Merck & Co., Inc. $MRK - MarketBeat
D.A. Davidson & CO. Raises Stake in Merck & Co., Inc. $MRK - MarketBeat
Ashton Thomas Private Wealth LLC Sells 49,784 Shares of Merck & Co., Inc. $MRK - MarketBeat
Advisors Capital Management LLC Has $17.34 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Price, Quote & Chart | MERCK & CO. INC. (NYSE:MRK) - ChartMill
Merck & Co. Inc. (MRK): One of the Best Low Risk High Growth Stocks to Buy Right Now - Insider Monkey
Teachers Retirement System of The State of Kentucky Raises Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Vanguard Group Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Acquired by Supplemental Annuity Collective Trust of NJ - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Sanctuary Advisors LLC - MarketBeat
Impax Asset Management Group plc Decreases Stock Position in Merck & Co., Inc. $MRK - MarketBeat
M&T Bank Corp Sells 1,452,939 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK Stock Quote Price and Forecast - CNN
Merck & Co., Inc. $MRK Stake Increased by AEGON ASSET MANAGEMENT UK Plc - MarketBeat
Merck and the Healthcare Sector Rotation Analysis - HarianBasis.co
Merck & Co., Inc. $MRK is Munich Reinsurance Co Stock Corp in Munich's 4th Largest Position - MarketBeat
J.P. Marvel Investment Advisors LLC Has $3.02 Million Holdings in Merck & Co., Inc. $MRK - MarketBeat
Concurrent Investment Advisors LLC Grows Position in Merck & Co., Inc. $MRK - MarketBeat
Generali Investments Management Co LLC Raises Stock Position in Merck & Co., Inc. $MRK - MarketBeat
China Universal Asset Management Co. Ltd. Sells 19,894 Shares of Merck & Co., Inc. $MRK - MarketBeat
Jim Cramer Says “Merck Is Terrific” - Insider Monkey
Merck Wins First Trial Over Cosmetic Talc Products Dr. Scholl's, Lotrimin - Law.com
Is Merck & Co. (MRK) One of the Best Bear Market Stocks to Invest in Right Now? - Insider Monkey
Infinimmune and Merck (MRK) Enter into an Antibody Discovery Agreement - Insider Monkey
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, - PharmiWeb.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc. - BioSpace
Merck & Co., Inc. $MRK Shares Purchased by Cadinha & Co. LLC - MarketBeat
Arizona State Retirement System Sells 31,306 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Merck & Co., Inc. $MRK Shares Sold by Teacher Retirement System of Texas - MarketBeat
United Asset Strategies Inc. Boosts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. (MRK) Gains FDA Priority Review for KEYTRUDA Regimen in Muscle-Invasive Bladder Cancer - Insider Monkey
Merck & Co., Inc. $MRK Shares Bought by Caprock Group LLC - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
3.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):